Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

Success Metrics

Active Trials

2(67%)

Phase Distribution

Not Applicable

67%

Phase 2

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Other(1)

Detailed Status

Recruiting2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 2

Trials by Phase

Phase 21 (33.3%)

N/A2 (66.7%)

Trials by Status

recruiting267%

unknown133%

Recent Activity

2 active trials

Showing 3 of 3

recruitingnot_applicable

Clinical Trials (3)

Showing 3 of 3 trials

NCT06518824Not Applicable

Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease

Recruiting

NCT06529380Not Applicable

Deep Brain Stimulation for Severe Self-Injurious Behaviour in Children

Recruiting

NCT04938154Phase 2

A Phase 2 Trial of Deep Brain Stimulation for Spasmodic Dysphonia

Unknown

All 3 trials loaded

Drug Details

Intervention Type: Device
Total Trials: 3